28th October 2021
Today the Department of Health and Social Care issued an updated Supply Disruption Alert confirming that there is no resupply date of varenicline from Pfizer and no alternative supplier. We have updated our guidance document below.
--
14th October 2021.
Pfizer have announced a wholesale and pharmacy recall of Champix. We understand that supply of varenicline will not be reinstated in the short term and so stop smoking services, health care professionals and smokers should all plan to use an alternative stop smoking medication such as combination NRT or bupropion (Zyban). We have updated our guidance document below.
--
18th June 2021.
It is worth remembering that we simply don't have scientific evidence for the clinical situation facing clients having to switch from Champix mid-course to an alternative stop smoking medication, we're making a best judgement call. We will update the guidance as necessary and date the document link below whenever an edit has been made.
The second attachment contains the questions we've been asked about helping clients to switch from Champix, and our answers, since news of the supply problems were announced.
--
16th June 2021.
The NCSCT produced clinical guidance on helping clients to switch from Champix (e.g. to combination NRT) in response to supply issues with Champix announced by Pfizer.
This briefing reports on the findings of the large and comprehensive EAGLES study into the safety and efficacy of varenicline, and on the changes to the summary of product characteristics.